UMIN ID: UMIN000001505
Registered date:03/07/2009
The phase II study of hypo-fractionated proton beam therapy for mucosal melanoma of the head and neck
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Mucosal melanoma of the head and neck |
Date of first enrollment | 2009/07/01 |
Target sample size | 35 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Proton beam therapy 60GyE/15fr/5w |
Outcome(s)
Primary Outcome | Local control rate |
---|---|
Secondary Outcome | Overall survival Acute toxicity Late toxicity |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1.with active other carcinoma 2.with mental disorder 3.recieve systemic steroid therapy 4.with active infectious disease |
Related Information
Primary Sponsor | National Cancer Center Hospital East Division of Radiation Oncology |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Self funding |
Secondary ID(s) |
Contact
public contact | |
Name | Sadamoto Zenda |
Address | 6-5-1 Kashiwanoha Kashiwa Chiba Japan |
Telephone | 04-7133-1111 |
szenda@east.ncc.go.jp | |
Affiliation | National Cancer Center Hospital East Division of Radiation Oncology |
scientific contact | |
Name | Sadamoto Zenda |
Address | 6-5-1 Kashiwanoha Kashiwa chiba, Japan Japan |
Telephone | 04-7133-1111 |
szenda@east.ncc.go.jp | |
Affiliation | National Cancer Center Hospital East Division of Radiation Oncology |